
R&D Services
Our R&D Services offer


Drug repositionning

Multi-catalysis

Late Phase development

Early Phase development

Custom ingredients

Personal care

High-Potency APIs (HPAPIs)

Solid state

Artificial Intelligence

Toxicology

Polymers

Biocatalysis

Applicative R&D
#News
Seqens to Unveil New Innovation and Development Center of Excellence
Seqens, an integrated global leader in pharmaceutical synthesis and specialty ingredients, will open a 34,000-square-meter lab today that is close to Paris…
Read moreSeqens’Lab Unveiling
Seqens is unveiling its main innovation and development centre in the presence of Ms. Agnès Pannier-Runacher, Secretary of State to the Minister…
Read moreSEQENS mobilizes its innovation to support the unprecedented research on the COVID-19 and prepares its unique industrial network for anti-virus production, for example hydroxychloroquine.
Pending the availability of a vaccine, which will necessarily take time, the race against the clock is underway for the identification and…
Read morePorcheville obtained its GMP certificate
SEQENS R&D Center in Porcheville, France, confirms its status as a center of excellence On 21 January 2019, the French National Agency for…
Read moreApplying Enzymatic Synthesis for Chiral Molecules
Pharma’s Almanac Magazine Advances in our understanding of enzymatic transformations and the increased availability of enzymes engineered for use in fine chemical synthesis…
Read moreGenEvolution: awarded at the “Entrepreneur Prize” trophies of the Grand Paris Seine & Oise
On the evening of Tuesday, March 19, 2019, GenEvolution, based at the Porcheville Seqens site, received two awards: the Public Prize and the Innovation…
Read moreInterview of Christelle FERRAGUT & Guillaume NOTHEAUX (Advanced Specialties) about Lubricant Business Line.
Lubricant additives & grease at Seqens “We do not sell a molecule, we sell a performance.” How much do you know Lubricant additives ? An…
Read moreWhat flow chemistry and biocatalysis bring to synthesize a typical small molecule candidate against Covid-19 epidemic
Efficient and safe process design combining SEQENS technical capabilities: Brilacidin as a case study As already mentioned in our previous article (“Seqens…
Read more